SEC Form 4 · accession 0001437749-17-012172
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J. Regan
Officer — SVP & CCO
Period of report
Jun 29, 2017
Accepted (ET)
Jul 3, 2017 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2017 | P | 20,000 | $0.5293 | A | 172,977 | D |
Table II — derivative securities
No Table II lines on this filing.